Huiting Dong

821 total citations
18 papers, 455 citations indexed

About

Huiting Dong is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Huiting Dong has authored 18 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Huiting Dong's work include Cancer Cells and Metastasis (5 papers), Cancer Risks and Factors (3 papers) and Breast Cancer Treatment Studies (3 papers). Huiting Dong is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Risks and Factors (3 papers) and Breast Cancer Treatment Studies (3 papers). Huiting Dong collaborates with scholars based in China, Austria and Hungary. Huiting Dong's co-authors include Jiguang Li, Qun Liu, Peng Xing, Yingying Xu, Feng Jin, Xinyu Zheng, Tingting Zhao, Zhi‐Feng Miao, Guolian Zhu and Feng Jin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of the American Academy of Dermatology and Medicine.

In The Last Decade

Huiting Dong

18 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huiting Dong China	12	199	160	129	97	87	18	455
Yang Brooks United States	7	337 1.7×	160 1.0×	115 0.9×	26 0.3×	37 0.4×	8	627
Diederik van Bodegom United States	7	185 0.9×	101 0.6×	42 0.3×	42 0.4×	47 0.5×	10	360
Ery Kus Dwianingsih Indonesia	12	175 0.9×	142 0.9×	117 0.9×	38 0.4×	32 0.4×	66	456
Mark E. Drotar United Kingdom	9	401 2.0×	187 1.2×	75 0.6×	71 0.7×	56 0.6×	15	753
Akash Gupta United States	11	157 0.8×	100 0.6×	53 0.4×	33 0.3×	77 0.9×	41	412
Nelson Rangel Colombia	12	192 1.0×	131 0.8×	135 1.0×	37 0.4×	119 1.4×	28	395
Martha Kimos United States	12	341 1.7×	71 0.4×	104 0.8×	69 0.7×	46 0.5×	13	615
Arata Shimo Japan	11	397 2.0×	154 1.0×	139 1.1×	55 0.6×	37 0.4×	17	610
G. Pommier France	11	242 1.2×	92 0.6×	97 0.8×	49 0.5×	60 0.7×	24	465
Philip Eliades United States	9	193 1.0×	245 1.5×	58 0.4×	36 0.4×	52 0.6×	12	481

Countries citing papers authored by Huiting Dong

Since Specialization

Citations

This map shows the geographic impact of Huiting Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiting Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiting Dong more than expected).

Fields of papers citing papers by Huiting Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiting Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiting Dong. The network helps show where Huiting Dong may publish in the future.

Co-authorship network of co-authors of Huiting Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Huiting Dong. A scholar is included among the top collaborators of Huiting Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiting Dong. Huiting Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Qun, Yu Cao, Xiaolin Wei, et al.. (2023). Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer. Cell Death and Disease. 14(12). 803–803. 5 indexed citations

Liu, Qun & Huiting Dong. (2021). EIF4A3‐mediated hsa_circ_0088088 promotes the carcinogenesis of breast cancer by sponging miR‐135‐5p. Journal of Biochemical and Molecular Toxicology. 35(11). e22909–e22909. 11 indexed citations

Liu, Qun, Huiting Dong, Tingting Zhao, et al.. (2021). Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC. Endocrine Related Cancer. 29(3). 139–149. 11 indexed citations

Dong, Huiting, Qun Liu, Tingting Zhao, et al.. (2019). Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity. Molecular Therapy — Nucleic Acids. 19. 696–705. 35 indexed citations

Jin, Feng, Jiguang Li, Yingying Xu, et al.. (2018). TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway. Journal of Cancer. 9(8). 1349–1356. 48 indexed citations

He, Zheng, Tingting Zhao, Feng Jin, et al.. (2018). Downregulation of RASSF6 promotes breast cancer growth and chemoresistance through regulation of Hippo signaling. Biochemical and Biophysical Research Communications. 503(4). 2340–2347. 16 indexed citations

Liu, Qun, et al.. (2018). Preoperative assessment of axillary lymph node status in breast cancer patients by ultrasonography combined with mammography. Medicine. 97(30). e11441–e11441. 20 indexed citations

Xing, Peng, Huiting Dong, Qun Liu, et al.. (2018). ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer. Cellular Physiology and Biochemistry. 49(3). 961–970. 23 indexed citations

Xing, Peng, Huiting Dong, Qun Liu, et al.. (2017). Upregulation of transmembrane 4 L6 family member 1 predicts poor prognosis in invasive breast cancer. Medicine. 96(52). e9476–e9476. 14 indexed citations

10.

Zhao, Tingting, Feng Jin, Jiguang Li, et al.. (2017). Dietary isoflavones or isoflavone-rich food intake and breast cancer risk: A meta-analysis of prospective cohort studies. Clinical Nutrition. 38(1). 136–145. 81 indexed citations

11.

Xing, Peng, Huiting Dong, Qun Liu, et al.. (2017). Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study. Oncotarget. 8(60). 102499–102510. 6 indexed citations

12.

Li, Jiguang, Peng Xing, Liang Feng, et al.. (2014). The value of substratified combined imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses. Breast Cancer Research and Treatment. 144(2). 391–396. 4 indexed citations

13.

Xing, Peng, et al.. (2013). Prognostic significance of body mass index in breast cancer patients with hormone receptor-positive tumours after curative surgery. Clinical and investigative medicine. 36(6). E297–E305. 10 indexed citations

14.

Xing, Peng, Jiguang Li, Feng Jin, et al.. (2011). Clinical and Biological Significance of Hepsin Overexpression in Breast Cancer. Journal of Investigative Medicine. 59(5). 803–810. 32 indexed citations

15.

Xing, Peng, Jiguang Li, Tingting Zhao, et al.. (2011). Fascin, an actin‐bundling protein, promotes breast cancer progression in vitro. Cell Biochemistry and Function. 29(4). 303–310. 30 indexed citations

16.

Liu, Qun, Jiguang Li, Xinyu Zheng, Feng Jin, & Huiting Dong. (2009). Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas. Chinese Medical Journal. 122(22). 2763–2769. 66 indexed citations

17.

Dong, Huiting, Helmut Kerl, & Lorenzo Cerroni. (2002). EMLA^® cream‐induced irritant contact dermatitis. Journal of Cutaneous Pathology. 29(3). 190–192. 15 indexed citations

18.

Kaddu, Steven, et al.. (2002). Warty dyskeratoma—“follicular dyskeratoma”: Analysis of clinicopathologic features of a distinctive follicular adnexal neoplasm. Journal of the American Academy of Dermatology. 47(3). 423–428. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact